A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Siqing Fu, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China
Xiaohui Niu, MDRecruiting - the First Affiliated Hospital of Sun Yat-Sen University
Guangdong, Guangzhou, China
Jingnan Shen, MDRecruiting - Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China
Completed - Henan Cancer Hospital
Zhengzhou, Henan, China
Active, not recruiting - the First Affiliated Hospital of Zhengzhou Universtity
Zhengzhou, Henan, China
Completed - Jiangsu Province Hospital
Nanjing, Jiangsu, China
Active, not recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Active, not recruiting - Liaoning Cancer Hospital
Shenyang, Liaoning, China
Completed - Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Completed - Shanghai Sixth People'S Hospital
Shanghai, Shanghai Municipality, China
Completed - Xi'An Hong Hui Hospital
Xian, Shanxi, China
Zhichao Tong, MDRecruiting - West China Hospital of Sichuan University
Chengdu, Sichuan, China
Yong Zhou, MDRecruiting - the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Zhaoming Ye, MDRecruiting
- Precision Nextgen Oncology
Beverly Hills, California, United States
Active, not recruiting - Scri at Healthone
Denver, Colorado, United States
Completed - the Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
Completed - Md Anderson Cancer Center
Houston, Texas, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jan 2020
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 19 Mar 2026
- Registered enrollment
- 276
- Registry id
- NCT04192344
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.